SCLX
Scilex Holding Company
NASDAQ · Healthcare · Drug Manufacturers - General · US
$5.42
+2.56%Forward multiples
Based on analyst estimates
- P/E forward
- 58.02x
- P/E 2026E
- —
- P/E 2027E
- 12.27x
- P/E 2028E
- 1.32x
- P/S forward
- 0.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.15x
- Price / sales
- 1.45x
- Price / cash flow
- -2.63x
Enterprise value
- Enterprise value
- $138.8M
- EV / sales
- 4.39x
- EV / EBITDA
- -0.38x
- EV / EBIT
- -0.49x
- Market cap
- $46.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026